IMBIO
Live / Registered — Registered and renewed (as of 16 Apr 2021)
What this means for you
Registered since 04 Jan 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Jan 2021).
Record
- Serial number
- 77827046
- Registration number
- 3898583
- Mark type
- Stylized text
- Filed
- 15 Sept 2009
- Published for opposition
- 19 Oct 2010
- Registered
- 04 Jan 2011
- Next maintenance due
- 04 Jan 2021
- Attorney of record
- Cheryl A. Clarkin, Esq.
Goods and services
- Class 010 — Medical apparatus: MEDICAL DEVICES, NAMELY, EMBOLIC AND HEMOSTATIC DEVICES FOR TREATING TUMORS, VASCULAR TRAUMA AND ANOMALIES VASCULATURE OF THE BODY, CATHETERS, GUIDEWIRES AND STENTS
- Class 042 — Scientific and technological services: MEDICAL AND SCIENTIFIC RESEARCH IN THE AREA OF VASCULARIZED TUMORS, ANEURYSMS, ARTERIORVENOUS MALFORMATIONS, ENDOLEAKS AND VARICOCELES
Owner
- IMBiotechnologies Ltd., Edmonton, Alberta, CA
- IMBiotechnologies Ltd., Edmonton, Alberta, CA
- IMBiotechnologies Ltd., Edmonton, Alberta, CA
Prosecution history
- 21 Sept 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Sept 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 21 Sept 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Sept 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Apr 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Apr 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Apr 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Apr 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Jan 2021 — TEAS SECTION 8 & 9 RECEIVED
- 04 Jan 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 Sept 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Aug 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Aug 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Mar 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Mar 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.